India may allow to minimise gap between Covishield doses sold privately: Report ruchika24 Sep 2021 5:15 AM GMTNew Delhi: India is likely to allow a smaller gap between AstraZeneca COVID-19 vaccine doses for inoculations being carried out privately, in line with...
No quarantine relief for Indians despite UK nod to Covishield as qualified vaccine ruchika23 Sep 2021 8:30 AM GMTNew Delhi: Indian travellers vaccinated with two doses of Covishield will still have to undergo 10 days of quarantine in the UK even as the vaccine has...
New brand names authorized for 3 Covid-19 vaccines in Canada, Details Medical Dialogues Team17 Sep 2021 8:48 AM GMTNew Delhi: Three approved Covid-19 vaccines manufacture by Pfizer-BioNTech , Moderna, and AstraZeneca will now be called Comirnaty, SpikeVax, and Vaxze...
EMA lists nerve disorder as side effect of AstraZeneca COVID vaccine MD Bureau11 Sep 2021 4:45 AM GMTAmsterdam: The European health regulatory body has listed Guillain-Barre Syndrome (GBS) -- a neurological disorder -- as a 'very rare' side effect of t...
Booster doses of Pfizer, AstraZeneca COVID vaccines approved in UK MD Bureau10 Sep 2021 7:07 AM GMTLondon: The UK's health regulator has approved Pfizer and AstraZeneca vaccines for booster doses against Covid-19, even as the country's decision on th...
COVID-19 vaccines effective in obese people: A position statement from Obesity Society Hina Zahid7 Sep 2021 6:45 PM GMTTOS encourages individuals with obesity to undergo vaccination with any of the available vaccines authorized for emergency use by the U.S. Food and Dru...
AstraZeneca gets nod for CKD, type 2 diabetes treatment Forxiga in Japan ruchika29 Aug 2021 4:45 AM GMTUK: AstraZeneca has recently announced that Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in Japa...
AstraZeneca arm halts trial on neurological disorder treatment ruchika22 Aug 2021 3:45 AM GMTNew Delhi: AstraZeneca's Alexion division will stop developing a treatment for the neurological disorder ALS due to lack of efficacy in a late-stage tr...
AstraZeneca Pharma India net profit down 45 percent to Rs 10.24 crore in Q1 ruchika10 Aug 2021 3:30 AM GMTNew Delhi: Drug firm AstraZeneca Pharma India on Monday reported a 45.03 per cent decline in its net profit to Rs 10.24 crore for the June ended quarte...
AstraZeneca India, BHU conduct cancer screening camp for women in Varanasi ruchika9 Aug 2021 6:30 AM GMTVaranasi: AstraZeneca India and the Banaras Hindu University (BHU) have recently conducted a cancer screening camp for women in Varanasi. This is the s...
AstraZeneca Saphnelo gets USFDA nod for treating Systemic Lupus Erythematosus ruchika3 Aug 2021 5:45 AM GMTNew Delhi: AstraZeneca has recently announced that the company has received approval in the United States (US) for Saphnelo (anifrolumab-fnia) for the ...
Setback to AstraZeneca: Delhi HC rejects plea against 9 pharma firms over Dapagliflozin Medical Dialogues Team26 July 2021 10:42 AM GMTNew Delhi: In a major setback to AstraZeneca and its Indian subsidiary ,the Delhi High Court has dismissed AstraZeneca's plea against nine generic phar...
